NRAS and colorectal carcinoma: Advanced CRC in 2021 is treated according to genetic alterations including the microsatellite stable (MSS) groups with KRAS/NRAS mutations, BRAF mutations, and KRAS/NRAS/BRAF WT, or microsatellite unstable (MSI) [5].